⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

April 1, 2011American Journal of Clinical Oncology

Role of FDG-PET/CT in Diagnosis, Staging, Response to Treatment, and Prognosis of Pancreatic Cancer

Gaia Grassetto Domenico Rubello

View Full Paper

Ask AI

Bookmark

Share

Abstract

From the Nuclear Medicine Service—PET/CT Centre, ‘Santa Maria della Misericordia Hospital,’ Rovigo, Italy. Reprints: Gaia Grassetto, MD, Department of Nuclear Medicine - PET/CT Centre, Medical Physics and Radiology, ‘Santa Maria della Misericordia’ Hospital, Viale Tre Martiri, 140, 45100, Rovigo, Italy. E-mail: [email protected].

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Grassetto et al. (2011) studied this question.

synapsesocial.com/papers/6a97ecb1da663e44ef77026e https://doi.org/10.1097/coc.0b013e3181d275a0

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Imaging a pancreatic carcinoma xenograft model with 11C-acetate: a comparison study with 18F-FDGOriginal Research · 2009 · 20 citations
2Role of 18F-fluorodeoxyglucose positron emission tomography imaging in surgery for pancreatic cancerPrognostic Study · 2008 · 73 citations
3Positron Emission Tomography/Computed Tomography Influences on the Management of Resectable Pancreatic Cancer and Its Cost-EffectivenessDiagnostic Study · 2005 · 322 citations
4The Clinical Usefulness of 18-Fluorodeoxyglucose Positron Emission Tomography in the Differential Diagnosis, Staging, and Response Evaluation After Concurrent Chemoradiotherapy for Pancreatic CancerCohort Study · 2006 · 178 citations
5Carcinoma of the Pancreatic Head and Periampullary Region Tumor Staging with Laparoscopy and Laparoscopic UltrasonographyCohort Study · 1995 · 320 citations